Testing effectiveness (Phase 2)Looking for participantsNCT05866432
What this trial is testing
Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases
Who this might be right for
Breast Cancer Stage IV
Medical University of Vienna 20